P27kif protein levels and E2F activity are targets of Cot kinase during G1 phase progression in T cells

被引:14
|
作者
Velasco-Sampayo, A [1 ]
Alemany, S [1 ]
机构
[1] Univ Autonoma Madrid, Fac Med, CSIC, Inst Invest Biomed, E-28029 Madrid, Spain
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 166卷 / 10期
关键词
D O I
10.4049/jimmunol.166.10.6084
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cot/Tpl-2 kinase, homologous to members of mitogen-activated protein kinase kinase kinase, was initially discovered by its capacity to promote cell transformation. Cot/Tpl-2 mRNA levels are increased during G(0) to G(1) phase progression in T lymphocytes, suggesting a role for this kinase later on in the cell cycle. The IL-2-dependent CTLL-2 cells were used to investigate the role of Cot kinase in G(1) to S phase transition. Transient expression of Cot kinase in CTLL-2 cells increases DNA synthesis triggered by IL-2 and the transient expression of a dominant negative form of Cot kinase in CTLL-2 markedly reduces the DNA synthesis triggered by this cytokine. Cell cycle analysis of synchronized CTLL-2 stabling overexpressing Cot kinase indicates that this kinase contributes to the passage to S and GZ-NI phases of the cell cycle. Cot kinase reduces the levels of the cyclin kinase inhibitor p27(kip), whereas bcl-x(L) expression is unaffected. Cot kinase also increases E2F transcriptional activity in a phosphatidylinositol 3 kinase-independent way and acts in synergy with this kinase. These data give evidence, for the first time, of the regulation of different G(1) progression events by Cot kinase.
引用
收藏
页码:6084 / 6090
页数:7
相关论文
共 50 条
  • [31] AP-1 blockade inhibits growth and suppresses G1 cyclin expression via down-regulation of E2F in breast cancer cells
    Shen, Q
    Lu, C
    Kim, HT
    Brown, PH
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S147 - S147
  • [32] ERα, SKP2 and E2F-1 form a feed forward loop driving late ERα targets and G1 cell cycle progression
    Zhou, W.
    Srinivasan, S.
    Nawaz, Z.
    Slingerland, J. M.
    ONCOGENE, 2014, 33 (18) : 2341 - 2353
  • [33] TM4SF5 accelerates G1/S phase progression via cytosolic p27Kip1 expression and RhoA activity
    Kim, Hyeonjung
    Lee, Jung Weon
    CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (02) : 167 - 167
  • [34] Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression
    Keenan, SM
    Lents, NH
    Baldassare, JJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (07) : 5387 - 5396
  • [35] ERα, SKP2 and E2F-1 form a feed forward loop driving late ERα targets and G1 cell cycle progression
    W Zhou
    S Srinivasan
    Z Nawaz
    J M Slingerland
    Oncogene, 2014, 33 : 2341 - 2353
  • [36] Role of the UBL-UBA protein KPC2 in degradation of p27 at G1 phase of the cell cycle
    Hara, T
    Kamura, T
    Kotoshiba, S
    Takahashi, H
    Fujiwara, K
    Onoyama, I
    Shirakawa, M
    Mizushima, N
    Nakayama, KI
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (21) : 9292 - 9303
  • [37] Overexpression of p27Kip1 lengthens the G1 phase in a mouse model that targets inducible gene expression to central nervous system progenitor cells
    Mitsuhashi, T
    Aoki, Y
    Eksioglu, YZ
    Takahashi, T
    Bhide, PG
    Reeves, SA
    Caviness, VS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (11) : 6435 - 6440
  • [38] TM4SF5 accelerates G1/S phase progression via cytosolic p27Kip1 expression and RhoA activity
    Kim, Hyeonjung
    Kang, Minkyung
    Lee, Sin-Ae
    Kwak, Tae Kyoung
    Jung, Oisun
    Lee, Hyo Jeong
    Kim, Sung-Hoon
    Lee, Jung Weon
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (08): : 975 - 982
  • [39] Relative non-steroidal anti-inflammatory drug (NSAID) antiproliferative activity is mediated through p21-induced G1 arrest and E2F inhibition
    Bock, Jonathan M.
    Menon, Sarita G.
    Goswami, Prabhat C.
    Sinclair, Lori L.
    Bedford, Nichole S.
    Domann, Frederick E.
    Trask, Douglas K.
    MOLECULAR CARCINOGENESIS, 2007, 46 (10) : 857 - 864
  • [40] G1/S-REGULATED E2F-CONTAINING PROTEIN COMPLEXES BIND TO THE MOUSE THYMIDINE KINASE GENE PROMOTER
    DOU, QP
    ZHAO, SC
    LEVIN, AH
    WANG, J
    HELIN, K
    PARDEE, AB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (02) : 1306 - 1313